首页   按分类浏览 期刊浏览 卷期浏览 CLINICAL EVALUATION OF ERYTHROMYCIN
CLINICAL EVALUATION OF ERYTHROMYCIN

 

作者: EMITT H. SHOEMAKER,   ELLARD M. YOW,  

 

期刊: A.M.A Archives of Internal Medicine  (JAMA Available online 1954)
卷期: Volume 93, issue 3  

页码: 397-406

 

ISSN:0888-2479

 

年代: 1954

 

DOI:10.1001/archinte.1954.00240270083008

 

数据来源: JAMA

 

摘要:

ERYTHROMYCIN is the generic name of an antibiotic derived from Streptomyces erythreus. Its discovery, method of production, and isolation as a crystalline material were described in June, 1952, by McGuire and co-workers.1Erythromycin is a basic compound soluble to the extent of 2 mg. per milliliter in water. It is extremely soluble in organic solvents, such as alcohol, acetone, chloroform, and ethyl acetate.1The crystalline material is grayish white and is stable at room temperature. The pH of a saturated solution of erythromycin is approximately 9. Aqueous solutions in high and low concentrations are stable for eight weeks at 4 C. in a frozen state. At room temperature there is some deterioration during the first week, but none has been demonstrated in the ensuing seven weeks. The antibacterial activity of broth solutions begins to decline on the fourth day. After this there is continuous progressive deterioration. Heating

 

点击下载:  PDF (1455KB)



返 回